The Recall Desk

Hazard

Mis Labeling recalls

9,611 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.

What the numbers show

Total
9,611
Critical
161
Severe
589
Most recent
2026-09-24

Of the 9,611 mis labeling recalls we have scored against our rubric, 161 (2%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 589 (6%) are Severe.

About this hazard tag

Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all mis labeling recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.

A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.

7701–7725 of 9611

  • ModerateFDA (Drugs)·D-966-2014·2014-01-29

    FDA Recalls Propafenone HCL Tablets Due to Potential Labeling Mixup

    Aidapak Services, LLC is recalling Propafenone HCL 150 mg tablets because they may have been mislabeled as Fosinopril Sodium 10 mg tablets.

    Product
    PROPAFENONE HCL, Tablet, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591058201.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-771-2014·2014-01-29

    Mycophenolate Mofetil Capsules Recalled for Potential Label Mixup

    Aidapak Services is recalling Mycophenolate Mofetil capsules due to a potential label mixup with Calcium Acetate.

    Product
    MYCOPHENOLATE MOFETIL, Capsule, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00004025901.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-997-2014·2014-01-29

    FDA Recalls Trifluoperazine Tablets Due to Potential Labeling Error

    Aidapak Services is recalling Trifluoperazine HCL tablets because they may have been mislabeled as Terbutaline Sulfate.

    Product
    TRIFLUOPERAZINE HCL, Tablet, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781103001.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-845-2014·2014-01-29

    Aidapak Recalls Losartan Potassium Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling Losartan Potassium 50 mg tablets because they may have been mislabeled as Midodrine HCL 2.5 mg.

    Product
    LOSARTAN POTASSIUM, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093736598.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-1009-2014·2014-01-29

    Aidapak Recalls Levothyroxine Sodium Tablets Due to Labeling Errors

    Aidapak Services is recalling Levothyroxine Sodium tablets because they may have been mislabeled as other prescription drugs.

    Product
    LEVOTHYROXINE SODIUM, Tablet, 88 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781518392.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-769-2014·2014-01-29

    Raloxifene HCL Tablets Recalled for Potential Label Mixup

    Aidapak Services is recalling Raloxifene HCL tablets due to a potential label mixup with Isosorbide Mononitrate.

    Product
    RALOXIFENE HCL, Tablet, 60 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00002416530.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-863-2014·2014-01-29

    Aidapak Recalls CapsuleTOPRIL Tablets Due to Potential Labeling Error

    Aidapak Services, LLC is recalling CapsuleTOPRIL tablets because they may have been mislabeled as Calcitriol capsules. The error could lead to patients receiving the wrong medication.

    Product
    CapsuleTOPRIL, Tablet, 12.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00143117101.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-880-2014·2014-01-29

    Aidapak Recalls Nabumetone Tablets Due to Potential Labeling Mixup

    Aidapak Services, LLC is recalling Nabumetone 500 mg tablets that may have been mislabeled as guaiFENesin ER 600 mg. The FDA classifies this as a Class II recall.

    Product
    NABUMETONE, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185014501.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Devices)·Z-0792-2014·2014-01-29

    Remel Recalls Oxoid Cefpodoxime Antimicrobial Susceptibility Test Discs

    Remel Inc is recalling Oxoid Cefpodoxime 10 mcg. Antimicrobial Susceptibility Test Discs because some cartridges may contain discs not impregnated with antibiotic.

    Product
    Oxoid Antimicrobial Susceptibility Test Discs, Cefpodoxime 10 mcg., CT1612B, packaged in cartridges of 50 discs, 5 cartridges/pack. The firm name on the label is Oxoid Ltd., Basingstoke, Hampshire, England. Used in the semi-quantitative agar diffusion test method for in-vitro su
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • ModerateFDA (Devices)·Z-0783-2014·2014-01-29

    Zimmer Segmental Systems Polyethylene Inserts Recalled for Loading Instructions

    Zimmer, Inc. is recalling Segmental Systems Polyethylene Inserts to update surgical instructions regarding excessive loading risks.

    Product
    Zimmer Segmental Systems; Polyethylene Inserts, Size B. Designed to address significant bone loss resulting from oncology, trauma, and/or salvage of previously failed arthroplasty.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • ModerateFDA (Devices)·Z-0820-2014·2014-01-29

    FDA Recalls Composix L/P Mesh Due to Labeling Mismatch

    Davol, Inc. is recalling 46 units of Composix L/P Mesh with Echo PS Positioning System because the product labeling does not match the product configuration.

    Product
    Composix L/P with Echo PS 6" X 8" Product Code 0144680 The Composix L/P Mesh with Echo PS Positioning System is a non-absorbable sterile lightweight mesh prosthesis, with a preattached removable positioning system. This system is indicated and designed for the reconstruction o
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • ModerateFDA (Devices)·Z-0803-2014·2014-01-29

    Civco Belly Board MRI Recalled Due to Misaligned Scales

    Civco Medical Instruments is recalling specific lots of Belly Board MRI devices because scales may be misaligned, potentially affecting measurement accuracy.

    Product
    Civco Belly Board MRI, Reusable non-sterile glass fiber belly board with cushion, REF 126000, packaged 1 per box. Product Usage: This device is intended to reduce the irradiated small bowel volume of gynecological patients undergoing treatment in the pelvic region.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-945-2014·2014-01-29

    Aidapak Recalls Niacin TR Tablets Due to Potential Label Mixup

    Aidapak Services is recalling Niacin TR 1000 mg tablets because they may have been mislabeled as 750 mg tablets. The repacked drugs were distributed in four western states.

    Product
    NIACIN TR, Tablet, 1000 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00536703801.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-971-2014·2014-01-29

    Aidapak Recalls Pioglitazone Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling 15 mg Pioglitazone tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.

    Product
    PIOGLITAZONE, Tablet, 15 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591320530.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-905-2014·2014-01-29

    Temazepam Capsules Recalled for Potential Labeling Mixup

    Aidapak Services is recalling Temazepam 7.5 mg capsules because they may be mislabeled as Calcium Citrate or Valsartan.

    Product
    TEMAZEPAM, Capsule, 7.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378311001.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-813-2014·2014-01-29

    Aidapak Recalls RILUZOLE Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling RILUZOLE 50 mg tablets because they may have been mislabeled as LACTOBACILLUS 0 mg tablets.

    Product
    RILUZOLE, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00075770060.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-943-2014·2014-01-29

    FDA Recalls Vitamin B Complex Capsules Due to Labeling Error

    Aidapak Services is recalling Vitamin B Complex capsules that may have been mislabeled as Acarbose tablets. The error involves a label mixup.

    Product
    VITAMIN B COMPLEX, Capsule, 0 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536478701.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-964-2014·2014-01-29

    Aidapak Recalls Triamterene/Hydrochlorothiazide Tablets Due to Labeling Error

    Aidapak Services, LLC is recalling Triamterene/Hydrochlorothiazide tablets because they may have been mislabeled as Sevelamer HCl.

    Product
    TRIAMTERENE/ HYDROCHLOROTHIAZIDE, Tablet, 37.5 mg/25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591042401.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-934-2014·2014-01-29

    Aidapak Recalls Docusate Calcium Capsules Due to Labeling Errors

    Aidapak Services, LLC is recalling 1,109 docusate calcium capsules because they may have been mislabeled as other medications. The affected products were distributed in four western states.

    Product
    DOCUSATE CALCIUM, Capsule, 240 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536375501.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-886-2014·2014-01-29

    Aidapak Recalls Hydrochlorothiazide Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling Hydrochlorothiazide 12.5 mg tablets because they may have been mislabeled as other prescription drugs.

    Product
    HYDROCHLOROTHIAZIDE, Tablet, 12.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00228282011.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-802-2014·2014-01-29

    Aidapak Recalls Phenol Lozenges Due to Potential Labeling Errors

    Aidapak Services, LLC is recalling Phenol Lozenges because they may have been mislabeled as Atorvastatin Calcium or Vitamin B Complex W/C tablets.

    Product
    PHENOL, LOZENGE, 29 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00068021918.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-942-2014·2014-01-29

    Aidapak Recalls Pyridoxine HCL Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling Pyridoxine HCL 100 mg tablets because they may have been mislabeled as other drugs. The repacked drugs were distributed in four western states.

    Product
    PYRIDOXINE HCL, Tablet, 100 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536440901.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-949-2014·2014-01-29

    FDA Recalls Isoniazid Tablets Due to Potential Labeling Errors

    Aidapak Services, LLC is recalling Isoniazid 300 mg tablets because they may have been mislabeled as other prescription drugs.

    Product
    ISONIAZID, Tablet, 300 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00555007102.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-853-2014·2014-01-29

    Aidapak Recalls glyBURIDE Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling glyBURIDE tablets because they may have been mislabeled as CYPROHEPTADINE HCL or AMANTADINE HCL.

    Product
    glyBURIDE, Tablet, 1.25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093834201.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-817-2014·2014-01-29

    Valsartan 320 mg Tablets Recalled for Potential Labeling Error

    Aidapak Services is recalling Valsartan 320 mg tablets because they may have been mislabeled as Cilostazol 100 mg.

    Product
    VALSARTAN, Tablet, 320 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078036034.
    Category
    Drug
    Distribution
    4 states